TY - JOUR
T1 - Mechanical dyssynchrony and functional mitral regurgitation
T2 - Pathophysiology and clinical implications
AU - Agricola, Eustachio
AU - Galderisi, Maurizio
AU - Mele, Donato
AU - Ansalone, Gerardo
AU - Dini, Frank Loyd
AU - Di Salvo, Giovanni
AU - Gallina, Sabina
AU - Montisci, Roberta
AU - Sciomer, Susanna
AU - Di Bello, Vitantonio
AU - Mondillo, Sergio
AU - Marino, Paolo Nicola
PY - 2008/5
Y1 - 2008/5
N2 - Functional mitral regurgitation (FMR) is a common finding in patients with ischemic or nonischemic dilated cardiomyopathy as a complication of left ventricular (LV) dysfunction and remodeling associated with a fibrotic remodeling response of mitral leaflets to abnormal valvular loading. Although mitral valve tenting is the main determinant of FMR, clinical and experimental observations suggest that intraventricular delay could be a potential co-determinant of FMR. LV dyssynchrony can potentially contribute to FMR by several mechanisms, such as creating an uncoordinated regional LV mechanical activation in segments supporting the papillary muscles, determining diastolic mitral regurgitation, reducing the sphincteric function of the mitral annulus, and decreasing the efficiency of LV contraction and closing forces. Cardiac resynchronization therapy has been demonstrated to reduce FMR with correction of some of the underlying pathophysiological mechanisms. The present review article focuses on the role of mechanical dyssynchrony as a pathophysiological determinant of FMR, and on the potential role of cardiac resynchronization therapy as a therapeutic option for treatment of FMR in patients with severe heart failure and advanced LV dysfunction.
AB - Functional mitral regurgitation (FMR) is a common finding in patients with ischemic or nonischemic dilated cardiomyopathy as a complication of left ventricular (LV) dysfunction and remodeling associated with a fibrotic remodeling response of mitral leaflets to abnormal valvular loading. Although mitral valve tenting is the main determinant of FMR, clinical and experimental observations suggest that intraventricular delay could be a potential co-determinant of FMR. LV dyssynchrony can potentially contribute to FMR by several mechanisms, such as creating an uncoordinated regional LV mechanical activation in segments supporting the papillary muscles, determining diastolic mitral regurgitation, reducing the sphincteric function of the mitral annulus, and decreasing the efficiency of LV contraction and closing forces. Cardiac resynchronization therapy has been demonstrated to reduce FMR with correction of some of the underlying pathophysiological mechanisms. The present review article focuses on the role of mechanical dyssynchrony as a pathophysiological determinant of FMR, and on the potential role of cardiac resynchronization therapy as a therapeutic option for treatment of FMR in patients with severe heart failure and advanced LV dysfunction.
KW - Cardiac resynchronization therapy
KW - Functional mitral regurgitation
KW - Ventricular dyssynchrony
UR - http://www.scopus.com/inward/record.url?scp=42049093206&partnerID=8YFLogxK
U2 - 10.2459/JCM.0b013e3282ef39c5
DO - 10.2459/JCM.0b013e3282ef39c5
M3 - Review article
SN - 1558-2027
VL - 9
SP - 461
EP - 469
JO - Journal of Cardiovascular Medicine
JF - Journal of Cardiovascular Medicine
IS - 5
ER -